Added to YB: 2026-08-31
Pitch date: 2026-08-26
CRON.TO [neutral]
Cronos Group Inc.
-4.49%
current return
Author Info
No bio for this author
Company Info
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
Market Cap
CAD 1.3B
Pitch Price
CAD 4.90
Price Target
N/A
Dividend
N/A
EV/EBITDA
44.85
P/E
19.34
EV/Sales
3.16
Sector
Pharmaceuticals
Category
growth
Watchlist Inflections - Cronos Group Inc.
CRON.TO (earnings): Cronos’ Q2 confirmed an operating inflection: revenue rose 58% to $53.0M, gross margin reached a record 54%, adjusted EBITDA rose nearly eightfold to $13.1M, and operating income turned profitable for the first time. At roughly 9.4x annualized Q2 EBITDA, valuation looks compelling, but limited cannabis-industry familiarity, Israeli regulatory uncertainty, doubts about the economics’ durability, and better-understood opportunities elsewhere keep it on the watchlist; buybacks also remain modest against $800M+ of net cash.
Read full article (4 min)